Patient and Physician Behavior
Our work in Patient and Physician Behavior
-
Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 Pandemic
The researchers examine changes in health care use during the first 2 months of the COVID-19 pandemic in March and April of 2020 relative to March and April of 2019 and 2018, and to examine whether changes in use differ by patient’s zip code–level race/ethnicity or income.
Categorized in -
BMJ: What Current and Missing Data Can Teach Us About Medication Errors
The cost of medication errors worldwide exceeds $42 billion, or approximately 5%–6% of all hospitalizations. There are a number of cost-effective strategies that could be deployed to reduce the quantity of adverse drug events.
Categorized in -
Details Matter: Predicting When Nudging Clinicians Will Succeed or Fail
Subtle implementation details can greatly influence the effectiveness of behavioural nudges because of their inherent subjective and social nature
Categorized in -
Know Your Epidemic, Know Your Response: Early Perceptions of COVID-19 and Self-Reported Social Distancing in the United States
we study individual’s perceptions on COVID-19 and social distancing during the week of March 10–16, 2020, a week when COVID-19 was officially declared to be a pandemic by WHO and when new infections in the US were more than doubling every three days.
Categorized in -
The Need To More Effectively Regulate END Markets: A Primary Public Health Lesson of the US Vaping Associated Lung Injury Outbreak
The designation of END products as “tobacco products” rather than “medical products” in August 2016 meant manufacturers did not have to meet pharmaceutical safety standards; instead, minimal product safety regulations were imposed.
Categorized in -
New Digital Health Project Will Include Traditionally Underrepresented Americans
Ritika Chaturvedi will lead the American Life in Real-time (ALiR) project, which will use digital technologies to create precision public health interventions that focus on reducing health disparities.
-
Uptake of Infliximab Biosimilars Among the Medicare Population
Two years after launch, biosimilars for rheumatoid arthritis and other lifelong conditions captured little market share.
Categorized in -
State Approaches to Tackling the Opioid Crisis Through the Health Care System
States have implemented multiple strategies to enhance the capacity and quality of treatment services for opioid use disorder.
-
Pacula Examines Pitfalls in the Legalized Marijuana Marketplace
As the marijuana industry marches toward mainstream acceptance, policymakers are turning to Rosalie Liccardo Pacula to help ensure that its popularity does not outpace scientific understanding of its risks.
-
Age Differences in COVID-19 Risk Perceptions and Mental Health: Evidence From a National U.S. Survey Conducted in March 2020
U.S. adults who were relatively older appeared to have a more optimistic outlook and better mental health during the early stages of the pandemic.
Categorized in